Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Susanne Haneder"'
Autor:
Ansh Kapil, Andreas Spitzmüller, Nicolas Brieu, Susanne Haneder, Anatoliy Shumilov, Armin Meier, Fabiola Cecchi, Alice Barkell, Nathalie Harder, Katrin Mittermaier, Ana Hidalgo-Sastre, Regina Alleze, Markus Schick, Günter Schmidt, Hadassah Sade, Zenta Tsuchihashi, Fumitaka Suto, Mark Gustavson, J. Carl Barrett, Danielle Carroll
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Many targeted cancer therapies rely on biomarkers assessed by scoring of immunohistochemically (IHC)-stained tissue, which is subjective, semiquantitative, and does not account for expression heterogeneity. We describe an image analysis-base
Externí odkaz:
https://doaj.org/article/b0bb13ca3be44be6a20f420d905211e6
Autor:
Philipp Wortmann, Tze Heng Tan, Susanne Haneder, Andrea Ennio Storti, Ansh Kapil, Jon Chesebrough, Daniel Sutton, Michal Sulikowski, Arthur Lewis, Sofia Koch, Steve Sweet, Zifeng Song, David Chain, Yeoun Jin Kim, Nadia Luheshi, Krista Kinneer, Zachary A. Cooper, Marlon Rebelatto, Günter Schmidt, Hadassah Sade, J. Carl Barrett
Publikováno v:
Cancer Research. 82:452-452
Antibody-Drug-Conjugates (ADCs) are biopharmaceutical drugs designed for targeted tumor therapy, meant to improve therapeutic index by restricting drug delivery to tumor cells that express the target antigen. ADCs bind to the target molecule on the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b463ab10edf625a0099e7845ebd0f81d
https://doi.org/10.1158/1538-7445.am2022-452
https://doi.org/10.1158/1538-7445.am2022-452
Autor:
Katrin Schneider, Guenter Schmidt, Andreas Spitzmueller, J. Carl Barrett, Fabiola Cecchi, Susanne Haneder, Danielle Carroll, Mark Gustavson, Ansh Kapil, Ana Hidalgo-Sastre, Hadassah Sade, Regina Teichert, Sotirios Lakis, Anatoliy Shumilov, Sriram Sridhar, Magdalena Wienken
Publikováno v:
Cancer Research. 81:PD6-01
Background T-DXd (Enhertu®) is an FDA-approved antibody-drug conjugate (ADC) targeting HER2. T-DXd has shown anti-tumor activity, not only in patients with HER2-overexpressing (IHC3+/2+ ISH+) breast cancer (BC) but also in patients with BC with low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ceffb299c1b32d938b9c312e10c2b2d6
https://doi.org/10.1158/1538-7445.sabcs20-pd6-01
https://doi.org/10.1158/1538-7445.sabcs20-pd6-01
Publikováno v:
Pancreatology. 17:S11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d53183c914a9aec4574992c3bdc13236
https://doi.org/10.1016/j.pan.2017.05.034
https://doi.org/10.1016/j.pan.2017.05.034
Publikováno v:
Pancreatology. 13:S20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49496f3611214c92fb6115a79a3b11ad
https://doi.org/10.1016/j.pan.2013.04.060
https://doi.org/10.1016/j.pan.2013.04.060
Publikováno v:
Pancreatology. 13:S28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa52da61914f354cad3d79e287475077
https://doi.org/10.1016/j.pan.2013.04.090
https://doi.org/10.1016/j.pan.2013.04.090
Autor:
Sonja Berchtold, Detlef K. Bartsch, Peter Langer, Susanne Haneder, Björn Konukiewitz, Irene Esposito, Roland Moll, Günter Klöppel, Anna Melissa Schlitter, Angela Segler
Publikováno v:
Pancreatology. 13:S14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0656127435a09c7dbe5ff2ec0723b1a6
https://doi.org/10.1016/j.pan.2013.04.042
https://doi.org/10.1016/j.pan.2013.04.042